Skip to main content
. 2024 Jan 24;103(3):737–747. doi: 10.1007/s00277-023-05610-x

Fig. 3.

Fig. 3

Probability of survival in 69 MPN patients presenting with SVT (red line) and 165 age- and sex-matched patients without SVT at diagnosis (blue line). Median survival was 24 and 39 years for SVT and non-SVT groups, respectively (p = 0.02). Abbreviation: MPN, myeloproliferative neoplasm; SVT, splanchnic vein thrombosis